Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36a pseudogene 30 (RPL36AP30) is a pseudogene in the human genome[5]. Pseudogenes are non-coding genomic DNA sequences that resemble normal genes but are generally not transcribed into functional proteins, often due to mutations or absence of regulatory elements[5][4]. RPL36AP30 specifically is a processed pseudogene related to the functional ribosomal protein L36a gene; as such, it does not encode a functional protein and is not considered a therapeutic target, receptor, or enzyme. While pseudogenes can occasionally have regulatory roles in gene expression (e.g., via competing endogenous RNA mechanisms), there is no specific evidence supporting a functional or disease-related role for RPL36AP30[5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36a pseudogene 30 (RPL36AP30).